The anti-obesity effect of a combination of extracts made of Platycodon grandiflorum (PGE), Apium graveolens (AGE) and green tea (GTE) extracts was investigated in a high-fat diet-induced obese C57BL/6N mouse model. Body weight, epididymal adipose tissue weight, liver weight, adipocytes size and serum lipid profile, insulin, leptin and glucose levels were investigated. Additionally, hepatic steatosis, injury and oxidative burden were evaluated in the present study. The current study demonstrated that the PGE, AGE, and GTE (PAG) mixture were most effective in preventing obesity and its associated complications compared with the single extracts used alone. This was evidenced by the PAG's prevention of weight gain, reduction of adipocyte size, beneficial effects in serum lipid profile, levels of insulin, leptin and glucose, and the prevention of liver injury by reducing fat accumulation in the liver, decreased GOT and GPT enzymes and the upregulation of liver antioxidant enzymes. These results suggested that PAG may provide insights into functional food ingredients for use in the prevention of obesity.
Introduction
Obesity is a metabolic disease that has emerged over the past 3 decades as a major health drawback. The most recent data estimate that more than 1.9 billion adults of over the age of 18 are overweight, with over 650 million of them being obese (1) . In addition, while just under 1% of children and adolescents aged 5-19 were obese in 1975, data in 2016 revealed that more than 124 million children and adolescents (6% of girls and 8% of boys) were obese (2). Overweight and obesity increase the risk of many health problems. It has a harmful metabolic consequence on blood pressure, cholesterol, triglycerides, and insulin resistance, and increases the risks of coronary heart disease, ischemic stroke and type 2 diabetes mellitus (3) . It is also said to increase the risk of cancer of the breast, colon, prostate, endometrium, kidney and gallbladder, and mortality rates are increased by obesity (4) . Despite these complications of obesity, it is regarded as the most preventable cause of death (5) . Therefore, effective management is essential.
Several prevention/treatment options are available for the treatment of obesity. The most common treatment involves losing weight through healthy eating and physical exercise. When these methods are ineffective, weight loss medicines are recommended to treat overweight and obesity. However, concerns have been raised regarding the use of weight-loss medication whose side effects may outweigh their benefits. Most anti-obesity medications that were approved and marketed have now been withdrawn due to serious adverse effects. For instance, fenfluramine and dexfenfluramine, used to treat obesity, were recalled by the U.S. Food and Drug Administration (FDA) because of concerns related to heart valve problems (6) . Phentermine, diethylpropion, and mazindol were recalled by the European Medicines Agency (EMA) due to their overwhelming side effects (7) . Rimonabant, a selective CB1 blocker used to treat obesity that was available in 56 countries was never approved by the FDA and was recalled by the EMA because of raised concerns of psychiatric adverse disorders (8) . Therefore, there is a need for alternative therapy with little to no side effects on the management of obesity and its related complications. Herbal medicines have been used to control weight and treat obesity. For instance, an increasing number of clinical trials have confirmed the beneficial effects of green tea on obesity (9) . The anti-obesity effect of green tea is associated with its caffeine and catechins, (-)-epigallocatechin-3-gallate contents (10) .
Platycodon grandiflorum is a perennial plant of the Campanulaceae family used as herbal medicine for the treatment of respiratory disorders, asthma, and diabetes. It is rich in bioactive compounds including flavonoids, polyphenols, and the triterpenoid saponins, and possesses antioxidant, anticancer, anti-inflammatory, and hepatoprotective properties (11) (12) (13) (14) (15) . Platycodins from P. grandiflorum showed anti-obesity effects and lowered whole body cholesterol in a study (16) . Apium graveolens or celery, is a cultivated edible plant, commonly used as a vegetable and has medicinal properties spanning anti-inflammatory, antifungal, and antibacterial (17) (18) (19) , and is also used to treat a variety of diseases such as asthma, hepatitis, bronchitis, and gastrointestinal infections (20) . Celery has also been shown to reduce blood glucose, blood lipids, and blood pressure (21) . The main functional compounds found in celery are chlorogenic acid, luteolin, apiin and apigenin (22) . Green tea (Camellia sinensis) is among one of the most consumed beverages in the world. A large body of evidence points to the fact that green tea and its isolated compounds have anti-inflammatory, antibacterial, anti-viral and neuroprotective effects (9) . Over the past years, the anti-obesity effects of green tea in animals and humans have been closely studied as a hot topic in functional food research. Indeed, there are clinical shreds of evidence of the beneficial effects of green tea on obesity (23) (24) (25) . The main constituents of green tea are catechins with some amount of gallic acid, quercetin, kaempferol, myricetin, and chlorogenic acid (26) . The continuous search for better therapies for the treatment of obesity and its associated disorders has spark growing interest in the synergistic effects of various phytochemicals and plant extracts for the treatment of obesity. In this light, we sought to investigate the synergistic effects of P. grandiflorum, A. graveolens, and green tea in obesity and obesity-associated disorders induced by a high-fat diet as part of our on-going project to develop anti-obesity functional food products from a combination of different extracts whose efficacy will be better than other products in the market including green tea.
Materials and methods
Plant extraction. P. grandiflorum roots and A. graveolens leaves were procured from a local market (Jeonbuk, Korea) and a local farm (Busan, Korea), respectively. The plants were washed in distilled water and dried at 40̊C for 16 h. The P. grandiflorum roots and A. graveolens leaves (100 g each) were extracted in 80% ethanol (2,000 ml), respectively for 72 h. The extracted samples were filtered using a 0.45 µm filter paper (Advantec, Togo, Japan). The filtered samples were concentrated under reduced pressure and lyophilized to obtain the dry powder of P. grandiflorum roots extract (PGE) and A. graveolens leaves extract (AGE), which were stored at -20̊C for subsequent use. Green tea extract (total catechins ≥38%) was procured from Mirae Biotech Co., Ltd (Gyeonggi-do, Korea) and stored at -20̊C for direct use.
Animals and diet. C57BL/6N male mice (4 weeks of age) were procured from Orient Bio Inc. (Gwangju, Korea). The mice were handled and experiments were carried out based on Jeonju University Institutional Animal Care and Use Committee guidelines with permission to carry out the experiment obtained from Jeonju University (JJU-IACUC-2018-8). Following the institution's guidelines, the mice were maintained in standard environmental conditions at a temperature of -22±2̊C, humidity of 50-60%, and 12/12 h light-dark cycle. The Mice were fed with commercial standard laboratory diet and water ad libitum during an acclimatization period of 1 week. After acclimatization, the 35 mice were grouped into 7 groups and fed either with a normal diet (10% fat) or high-fat diet (HFD) (60% fat) for 16 weeks as follows: Group 1: Non-HFD fed group (ND), n=5. Group 2: HFD fed group (HFD), n=5. Group 3: HFD with 200 mg/kg PGE treatment, n=5. Group 4: HFD with 200 mg/kg AGE treatment, n=5. Group 5: HFD with 200 mg/kg GTE treatment, n=5. Group 6: HFD with 100 mg/kg PGE and 100 mg/kg AGE mixture treatment, n=5. Group 7: HFD with 200 mg/kg PGE, AGE, and GTE mixture (1:1:1 ratio) treatment, n=5. The extracts were orally administered on a daily basis for 16 weeks. The ND and HFD group received an equal amount of distilled water during extract administration. All mice were euthanized at the end of the experiment by cervical dislocation. Confirmation of death was done by ensuring a firm toe pinch and lack of visible respiration. No prior death was recorded for this experiment.
Body weight gain and food intake analysis. The weight of the mice in each group was recorded at the start of the experimental period and at the end of the experiment. The average difference between the initial and final weight was taken to be the average weight gain in each group. The amount of food intake was measured at the same time on the same day of the week during the 16 weeks experimental period. The average amount of daily food intake was calculated and recorded.
Serum biochemical analysis.
At the end of the 16-weeks experimental period, the mice were made to fast for 12 h and then were sacrificed. Blood was immediately collected through the intraorbital vein. The blood samples were centrifuged at 2,000 x g for 15 min at 4̊C, and the serum was separated and stored at -70̊C for subsequent use. The serum concentrations of total cholesterol (TC), high-density lipoprotein cholesterol (HDL-C), triglycerides (TG) (Asan Pharmaceutical Co., Ltd., Gyeonggi, Korea), leptin (R&D Systems, Inc., Minneapolis, MN, USA), insulin (Alpco Diagnostics, Windham, NH, USA), and glutamic oxaloacetic transaminase (GOT) and glutamic-pyruvic transaminase (GPT) (Asan Pharmaceutical Co., Ltd.) were analyzed by the use of a spectrophotometer (Tecan Group, Männedorf, Switzerland). Low-density lipoprotein cholesterol (LDL-C) was measured with the formula: LDL-C=TC-HDL-C-(TG/5). All experiments were carried out following the manufacturer's instructions. Blood glucose was measured with the aid of an Accu-Check glucometer (Roche Diagnostics, Risch-Rotkreuz, Switzerland).
Atherogenic index and cardiac risk factor measurement. The atherogenic index was measured with the formula: Atherogenic index=(TC-HDL)/HDL. The cardiac risk factor was measured with the formula: Cardiac risk factor=TC/HDL. Liver and adipose tissue analysis. After blood collection, liver and epididymal adipose tissues were removed from the mice and weighed immediately. For liver oxidative stress analysis, 0.3 g of liver tissues were obtained and homogenized in 0.5 ml of phosphate-buffered saline and then centrifuged at 2,000 x g for 15 min at 4˚C to obtain the supernatant which was stored at -70˚C. Catalase (CAT) activity and concentration of GSH (Cayman Chemical, Ann Arbor, MI, USA) were measured using assay kits, following the manufacturer's instructions using a Tecan spectrophotometer (Männedorf). For histochemistry analysis, epididymal adipose and liver tissues were fixed in 10% neutral formalin for 42 h. The tissues portions were placed in cassettes and washed in three changes of phosphate buffered saline (30 min for each wash); cleared in two changes of xylene (30 min each) and embedded in 3 changes of paraffin (1 h each). The tissues were blocked in paraffin and cut to a 5-µm thickness. The section tissues were stained with hematoxylin and eosin (H&E) and viewed under a light microscope (Leica, Wetzlar, Germany). The epididymal adipocyte size was evaluated using an ImageJ software program (developed by the National Institutes of Health, Bethesda, MD, USA). In addition, an independent who was blinded to the grouping of the mice expert examined the stained liver sections.
Statistical analysis. Differences between groups were appraised by analysis of variance (ANOVA) followed by Duncan's multiple-range test. All data are given as the mean ± SD (standard deviation). A P-value of <0.05 was set to indicate statistically significant results.
Results
Synergistic effects of PAG mixture on body weight, food intake, and food efficiency ratio. As shown in Fig. 1 , mice fed with HFD (HFD control group) significantly gained more weight compared to the mice fed with normal laboratory diet (ND group). When mice were fed with HFD and administered with either PGE, AGE, GTE, PA mixture or PAG mixture, weight gain was significantly decreased compared to the HFD group. Of note, mice treated with the PAG mixture recorded the least amount of weight gain as compared to the other treatment groups.
The daily food intake in mice fed with HFD was significantly decreased compared to mice in the ND group. However, HFD mice administered with either PGE, AGE, GTE, PA mixture or PAG mixture, had a significant increase in the daily food intake compared to the HFD control group. Food efficiency ratio was also significantly increased in the HFD control group compared to the ND group. The PGE, AGE, GTE, PA mixture or PAG mixture treatment groups showed a significant reduction in food efficiency ratio compared to the HFD control group. The PAG mixture treatment group recorded the least food efficiency ratio.
Synergistic effects of PAG mixture on serum lipid profile, atherogenic index, and cardiac risk factor. As presented in Fig. 2 , mice in the HFD control group showed a significant increase in serum triglyceride, total cholesterol, LDL-cholesterol, and HDL-cholesterol compared to the ND group. As compared to the mice in the HFD control group, all of the PGE, AGE, GTE, PA mixture or PAG mixture treatment groups showed a significant decrease in the levels of triglycerides ( Fig. 2A) . The total cholesterol (Fig. 2B) , and LDL-cholesterol (Fig. 2C) were also decreased in all treatment groups except the AGE treatment group, with the PAG treatment group recording the least levels. The HDL-cholesterol level in serum was also decreased but their differences were not significant among the treatment groups (Fig. 2D) .
The results of the atherogenic index and cardiac risk factor demonstrated that mice in the HFD control group had a significant increase in the atherogenic index and cardiac risk factors. However, only mice fed with HFD and administered with either GTE, PA mixture or PAG mixture had a significant reduction in the atherogenic index and cardiac risk factors, with the PAG mixture treatment group demonstrating better effects than the other treatment groups ( Fig. 2E and F) .
Synergistic effects of PAG mixture on energy balancing metabolism. As shown in Fig. 3 , mice in the HFD control group recorded a significant increase in blood glucose level, compared to mice in the ND group. Only the PA mixture and PAG mixture treatment groups had a significant reduction in serum glucose levels compared to the mice in the HFD control group (Fig. 3A) . Serum leptin levels were also significantly increased in mice of the HFD control group compared to the ND group. PGE, AGE, GTE, PA mixture or PAG mixture treatment groups recorded a significant decrease in leptin levels, compared to mice of the HFD control group (Fig. 3B) . Similarly, insulin levels were significantly increased in mice of the HFD control group. However, the PGE, AGE, GTE, PA mixture or PAG mixture had the tendency to downregulate serum insulin levels (Fig. 3C ). Among the treatment groups, the PAG mixture group appeared to have better effects on energy balancing metabolisms compared to the other groups.
Synergistic effects of PAG mixture on serum toxicity markers and liver oxidative stress. Mice fed with HFD resulted in a significant increase in the liver weight ( Fig. 1 ) and serum levels of GOT and GPT compared to mice fed with a normal diet ( Fig. 4A and B) . A significant decrease in endogenous GSH antioxidant and catalase activities in the liver tissues were also observed in mice fed with HFD compare to mice in the ND group ( Fig. 4C and D) . Treatment with either the PGE, AGE, GTE, PA mixture or PAG mixture significantly decreased liver weight, with the PAG treatment group demonstrating better effects than the other treatment groups (Fig. 1) . The serum GOT level was significantly decreased in the PA mixture and PAG mixture treatment group (Fig. 4A) , while serum GPT level was significantly decreased in the PGE, GTE, PA mixture, and PAG mixture treatment groups (Fig. 4B ). On the one hand, GSH antioxidant and catalase activities were significantly upregulated in all treated groups, with the PAG mixture treatment group demonstrating the best results ( Fig. 4C and D) . On the whole, the PGE, AGE, GTE, PA mixture or PAG mixture treatment showed no detectable adverse toxicity effects in the livers.
Synergistic effects of PAG mixture on adipose tissue and fat deposition. Mice fed with HFD resulted in a significant increase in the epididymal fat weight compared to mice that received the normal diet ( Fig. 1 ). However, mice fed with HFD and treated with either the PGE, AGE, GTE, PA mixture, or PAG mixture showed no significant decrease in the epididymal fat weight compared to the HFD control group (Fig. 1) . To estimate the adipocyte size, using Image software, the diameter of adipocytes in H&E stained sections were measured. The mice in the HFD control group showed a significant increase in adipocyte diameter size compared to the ND group. Of all the treatment groups, only the PAG group showed a significant decrease in adipocyte diameter compared to the HFD control group (Fig. 5A) . The adipocyte size can be seen clearly in the histological sections presented in Fig. 5B .
Histological stain liver sections also showed that the liver of mice in the HFD control group had extensive lipid droplet accumulation compared to the ND group (Fig. 5C ). Macrovesicular and micro lipid droplets could be seen in the liver sections of mice in the HFD control group thus demonstrating a typical fatty liver. All treatment groups showed less lipid droplet accumulation compared to the HFD control group. It is also of interest to note that the liver conditions of the PAG treatment group appeared to be close to those of the ND group (Fig. 5C ).
Discussion
With the increasing global prevalence of obesity and its associated disorders, coupled with the fact that therapies designated for the prevention and treatment of obesity most often render patients with severe consequences, alternative anti-obesity therapies from natural products have taken the lead in modern day research with the sole aim of developing better therapies for the prevention and treatment of obesity and its associated disorders. In the present study, we investigated the synergistic effects of PGE, AGE, and GTE in obesity induced by HFD in mice. It was found that the PGE, AGE, GTE, and PA mixture decreased the body weight of mice that were fed with HFD. Although no significant difference was found in the epididymal adipose tissue of the HFD control group and the treatment groups, histological examinations of the epididymal tissues, and measurement of the diameters of the adipocyte in different microscopic fields revealed that the PAG mixture treatment group had reduced adipose cell size. The results obtained from the PAG mixture treatment appeared to be most effective in preventing weight gain and inhibiting epididymal adipocyte size expansion in the obese mice. Also, the results of the daily food intake and food efficiency ratio further suggest that PAG was most effective in preventing body weight gain among the treatment groups. From these results, it can be inferred that PAG treatment has the potential to be used as an anti-obesity agent for preventing weight gain and preventing an increase in adipocyte size in obesity and its associated disorders.
In animals as well as in humans, obesity or a high-fat diet has been shown to influence lipid dynamics that result in or increase the risk of cardiovascular diseases. In this study, obesity led to an increment of serum lipid parameters such as TG, total cholesterol, LDL, and HDL. These disturbances in the lipid dynamics exposed the mice to the risk of developing cardiovascular diseases as revealed by the atherogenic index and cardiac risk factor data of this study. The study also showed that PGE, AGE, GTE, PA mixture, and PAG mixtures decreased the serum lipid parameters thereby decreasing the risk of cardiovascular disease, with the PAG mixture demonstrating the overall best effects. Previous studies have revealed the presence of hypolipidaemic compounds in PGE, AGE, and GTE (16, 21, 27) . The effects of these extracts and their combinations could act by directly preventing obesity and hence lipid serum levels or by decreasing cholesterol absorption or better still interfering in triglyceride or cholesterol synthesis. A study had earlier reported that phenols in apples were responsible for hypolipidemic and antiatherogenic in rats by suppressing cholesterol absorption while promoting its catabolism (28) .
Leptin and insulin among other hormones are key obesity markers that correlate positively with adiposity and an increase in fat mass and are involved in the regulation of appetite and satiety, thus affecting energy metabolism (29) . Also, leptin and insulin resistance is seen in obesity and its leads to hyperinsulinemia and hyperleptinemia (30, 31) . Thus, the normalization of these obesity-related parameters will lead to fat and glucose metabolism thus providing useful methods for treating obesity and its related complications. In the present study, serum insulin and leptin were increased with HFD treatment. HFD has been reported to increase insulin and leptin levels, causing hyperinsulinemia and hyperleptinemia (32) . It was also revealed in this study that treatment with PGE, AGE, GTE, PA mixture, and PAG mixtures suppressed the increase in insulin and leptin levels with PAG mixture demonstrating the overall best results. The effects of these extracts in decreasing insulin and leptin levels might also be responsible for the decrease in glucose levels seen with the extract treatment, especially with the PAG mixture treatment group. Several reports have shown a reduction in body weight gain with HFD treatment of mice through leptin modulation (33) (34) (35) . It is also of interest to note that insulin determines leptin levels (32) . Therefore, it can be concluded that a significant decrease in insulin level may have resulted in the suppression of leptin and hence glucose levels with the extracts treatment.
A high-fat diet is also well known to increase liver weight probably through fatty acid deposition, causes liver injury and also induces oxidative burden in mice liver. Consistently, feeding mice with HFD led to higher liver weight, while administration of the PGE, AGE, GTE, PA mixture, and PAG mixtures led to a decrease in liver weight. Histological findings using H&E staining revealed severe hepatic steatosis in HFD-fed mice. The presence of macrovesicular and micro lipid droplets could be seen in stained sections. In addition, HFD resulted in liver oxidative stress and injury as evidenced by enhanced GOT, GPT, and diminished catalase activity and GSH levels. Administration of PGE, AGE, GTE, PA mixture, and in particular PAG mixtures to mice fed with HFD reduced fatty acid deposition in the liver; reduced GOT and GPT; and up-regulated catalase activity and GSH levels in the mice. These results further suggest that PGE, AGE, and GTE combinations possess liver-protective actions.
The observed effects of PAG mixtures on weight gain, adipocyte size, lipid profiles, obesity-related hormones, and liver protection in our study were in compliance with reports from other studies. Varying combinations of Phyllostachys pubescens leaf extract and Scutellaria baicalensis root extract significantly reduced weight gain, adipose tissue weight, size of adipocytes, and the levels of glucose, leptin, and lipid profile in serum, and fat accumulation in the liver (36) . Treatment with mixtures of Salacia reticulate extract and cyclodextrin also significantly suppresses body weight gain, visceral fat mass plasma leptin, and TG levels of rats fed with HFD (37) . Here, we hypothesized that the potential mechanism of action of these extracts could involve increasing energy expenditure, enhancing lipolysis, preventing energy intake, and elevating fatty acid oxidation-related genes especially as one of the extracts used in this study (Green tea) had previously been shown to regulated these parameters in previous studies (9, 38) . The synergistic effects that were seen in this study could have arisen from an increase in the number or amount of antiobesity constituents as a result of combining the three extracts. Also, an important observation in this study was the fact that the combination of the three extracts did not demonstrate any adverse effects (evidenced by no mouse death recorded) as seen with drug-drug interaction in combinational therapies. In conclusion, oral administration of PAG mixture significantly reduced body weight, adipocyte size, serum triglyceride, total cholesterol, LDL cholesterol and leptin, insulin and glucose levels in high-fat-diet-induced obese mice. The mixed extract also decreased the serum levels of GOT and GPT, upregulated catalase activity and GSH level, thus preventing liver injury. Therefore, it can be assumed that a combination of Platycodon grandiflorum, Apium graveolens, and green tea exert anti-obesity effects. The overall findings of this study indicate that the PAG mixture is worthy of further investigation as a potential anti-obesity agent. As a limitation to the present study, multiple ratios of the extracts were not tested to determine the optimal ratio for better efficacy.
